Related Experiment Videos
Hot flashes: aetiology and management
D Barton1, C Loprinzi, D Wahner-Roedler
1Mayo Clinic, Rochester, Minnesota 55905, USA.
Drugs & Aging
|October 6, 2001
Summary
Hormone therapy is the most effective treatment for hot flashes, reducing them by 80-90%. Newer antidepressants like venlafaxine offer a 60% reduction, providing key options for menopause symptom management.
Area of Science:
- Reproductive Endocrinology
- Menopause Management
- Pharmacology
Background:
- Hot flashes are a common menopause symptom impacting quality of life.
- The precise pathophysiology of hot flashes remains unclear.
- Numerous treatment strategies are available for managing hot flashes.
Purpose of the Study:
- To provide evidence-based information on hot flash treatment options.
- To compare the efficacy of hormonal and nonhormonal therapies.
- To consider treatment for specific populations, like breast cancer survivors.
Main Methods:
- Review of pharmacological and nonpharmacological interventions.
- Analysis of treatment risks and benefits.
- Evidence-based assessment of treatment effectiveness.
Main Results:
- Hormone therapy (estrogen, progesterone, tibolone) is highly effective, reducing hot flashes by 80-90%.
- Selective serotonin reuptake inhibitors (SSRIs), such as venlafaxine, are the most effective nonhormonal option, yielding ~60% reduction.
- Treatment choice requires balancing risks and benefits for individual patients.
Conclusions:
- Hormone therapy remains the gold standard for hot flash reduction.
- Certain antidepressants offer significant relief for women seeking nonhormonal options.
- Personalized treatment strategies are essential for effective hot flash management, especially in vulnerable groups.